Cardiovascular and Mortality Outcomes in the Elderly With Impaired Cardiac and Pulmonary Function: The Cardiovascular Health Study (CHS)

Abstract

BackgroundImpaired pulmonary function (IPF) and left ventricular systolic dysfunction (LVSD) are prevalent in the elderly and are associated with significant morbidity and mortality. The main objectives of this study were to examine the relative impact and joint association of IPF and LVSD with heart failure, cardiovascular mortality and all‐cause mortality, and their impact on risk classification using a continuous net reclassification index.Methods and ResultsWe followed 2342 adults without prevalent cardiovascular disease (mean age, 76 years) from the Cardiovascular Health Study for a median of 12.6 years. LVSD was defined as LV ejection fraction <55%. IPF was defined as: forced expiratory volume in 1 second:forced vital capacity <70%, and predicted forced expiratory volume in 1 second <80%. Outcomes included heart failure hospitalization, cardiovascular mortality, all‐cause mortality, and composite outcome. LVSD was detected in 128 subjects (6%), IPF in 441 (19%) and both in 38 (2%). Compared to those without LVSD or IPF, there was a significantly increased cardiovascular risk for groups of LVSD only, IPF only, and LVSD plus IPF, adjusted hazard ratio (95% CI) 2.1 (1.5–3.0), 1.7 (1.4–2.1), and 3.2 (2.0–5.1) for HF; 1.8 (1.2–2.6), 1.4 (1.1–1.8), and 2.8 (1.7–4.7) for cardiovascular mortality; 1.3 (1.0–1.8), 1.7 (1.4–1.9), and 2.1 (1.5–3.0) for all‐cause mortality, and 1.6 (1.3–2.1), 1.7 (1.5–1.9), and 2.4 (1.7–3.3) for composite outcome, respectively. Risk classification improved significantly for all outcomes when IPF was added to the adjusted model with LVSD or LVSD to IPF.ConclusionsWhile risk of cardiovascular outcomes was the highest among elderly with both LVSD and IPF, risk was comparable between subjects with IPF alone and those with LVSD alone. This observation, combined with improved risk classification by adding IPF to LVSD or LVSD to IPF, underscore the importance of comprehensive heart and lung evaluation in cardiovascular outcome assessment.

Association of lung function with overall mortality is independent of inflammatory, cardiac, and functional biomarkers in older adults: the ActiFE-study

“…In general and middle-aged populations, studies found an association of FEV 1 with mortality 19 – 21 , and partly showed that FEV 1 was a better predictor than FVC 22 , while other studies reported a stronger association with FVC and less (or no) association with FEV 1 or airway obstruction 1 – 3 . In older populations, an association with FEV 1 23 and airway obstruction with all‐cause mortality 24 has been reported. We observed also a clear association for FEV 1 /FVC.…”

Predictors and outcomes of postoperative pulmonary complications following abdominal surgery in a South Indian population

“…Waheed et al . [ 20 ] have shown that impaired pulmonary function and cardiovascular functions are prevalent in the elderly and are an important cause of cardiovascular and all-cause mortality. They have recommended that isolated prevalence of either pulmonary or cardiovascular comorbidity can contribute to overall cardiovascular outcomes and have also recommended a comprehensive cardiac and pulmonary evaluation in the prediction of cardiovascular outcomes.…”

Treating multiple antiaging pathways improves health markers in open label clinical study

“…4). Impaired pulmonary function has been linked to greater risks of ill health and all-cause mortality [81]. In addition to being a reliable measure of pulmonary function, PEF has been shown to be a valid measure of overall health status and all-cause mortality [82][83][84][85][86].…”